Literature DB >> 30185433

Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons.

Cecilia Chavarría1, Sebastián Rodríguez-Bottero2, Celia Quijano1, Patricia Cassina2, José M Souza3.   

Abstract

Synucleinopathies are a group of neurodegenerative disorders characterized by the presence of aggregated and fibrillar forms of alpha-synuclein (α-syn). Here, we analyze the effect of different species of α-syn, including monomeric, oligomeric and fibrillar forms of the protein, on rat astrocytes. Astrocytes treated with these distinct forms of α-syn showed an increase in long and thin processes and glial fibrillary acidic protein expression, indicating cell activation, high levels of intracellular oxidants and increased expression of cytokines. Moreover, astrocytes incubated with the different species induced hippocampal neuronal death in co-culture, and cytotoxicity was particularly enhanced by exposure to fibrillar α-syn. Further exploration of the mechanisms behind astrocyte activation and cytotoxicity revealed differences between the assessed α-syn species. Only oligomers induced mitochondrial dysfunction in astrocytes and significantly increased extracellular hydrogen peroxide production by these cells. Besides, TNF-α and IL-1β (interleukin 1β) expression presented different kinetics and levels depending on which species induced the response. Our data suggest that α-syn species (monomeric, oligomeric and fibrillar) induce astrocyte activation that can lead to neuronal death. Nevertheless, the tested α-syn species act through different preferential mechanisms and potency. All together these results help to understand the effect of α-syn species on astrocyte function and their potential impact on the pathogenesis of Parkinson's disease and related α-synucleinopathies.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  astrocytes; cytokines; hydrogen peroxide; mitochondrial dysfunction; α-synuclein

Mesh:

Substances:

Year:  2018        PMID: 30185433     DOI: 10.1042/BCJ20180297

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

3.  Inhibition of α-Synuclein Accumulation Improves Neuronal Apoptosis and Delayed Postoperative Cognitive Recovery in Aged Mice.

Authors:  Yue Li; Yi Yuan; Yitong Li; Dengyang Han; Taotao Liu; Ning Yang; Xinning Mi; Jingshu Hong; Kaixi Liu; Yanan Song; Jindan He; Yang Zhou; Yongzheng Han; Chengmei Shi; Shun Yu; Peng Zou; Xiangyang Guo; Zhengqian Li
Journal:  Oxid Med Cell Longev       Date:  2021-05-28       Impact factor: 6.543

4.  Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation via Autophagy Activation in Primary Astrocytes.

Authors:  Juntao Cui; Yu Yuan; Jun Wang; Ning Song; Junxia Xie
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

5.  The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes.

Authors:  Andrés Vicente-Acosta; Alfredo Giménez-Cassina; Javier Díaz-Nido; Frida Loria
Journal:  J Neuroinflammation       Date:  2022-04-12       Impact factor: 8.322

6.  Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis.

Authors:  Lifu Sheng; Tessandra Stewart; Dishun Yang; Eric Thorland; David Soltys; Patrick Aro; Tarek Khrisat; Zhiying Xie; Na Li; Zongran Liu; Chen Tian; Matthew Bercow; Junichi Matsumoto; Cyrus P Zabetian; Elaine Peskind; Joseph F Quinn; Min Shi; Jing Zhang
Journal:  Acta Neuropathol Commun       Date:  2020-07-08       Impact factor: 7.801

7.  Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates.

Authors:  Leonardo Acuña; Sabah Hamadat; Natalia S Corbalán; Florencia González-Lizárraga; Mauricio Dos-Santos-Pereira; Jérémy Rocca; Julia Sepúlveda Díaz; Elaine Del-Bel; Dulce Papy-García; Rosana N Chehín; Patrick P Michel; Rita Raisman-Vozari
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

Review 8.  Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps.

Authors:  Taylor E Huntington; Rahul Srinivasan
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

Review 9.  No Longer Underappreciated: The Emerging Concept of Astrocyte Heterogeneity in Neuroscience.

Authors:  Francisco Pestana; Gabriela Edwards-Faret; T Grant Belgard; Araks Martirosyan; Matthew G Holt
Journal:  Brain Sci       Date:  2020-03-13

Review 10.  Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.

Authors:  Yoo Jin Jung; David Tweedie; Michael T Scerba; Nigel H Greig
Journal:  Front Cell Dev Biol       Date:  2019-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.